The most recent version of the NCCN Guidelines for Genetic and Familial CRC Syndromes (version 1.2021), indicates that no evidence has been established; therefore, the risk of colorectal cancer in carriers of ATM variants is uncertain. The gene discussed is ATM; the disease is colorectal cancer.